Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Leukocyte telomere length in a population-based case-control study of ovarian cancer: a pilot study
Cancer Causes and Control, 10/02/09
Mirabello L et al. – This study shows that short leukocyte telomeres are associated with serous ovarian adenocarcinoma.
Methods- 99 women with serous ovarian adenocarcinoma and 100 age-matched cancer-free controls enrolled
- Case-control study
- Investigated leukocyte telomere length
- Cases tended to have shorter telomeres than controls
- Compared to subjects with telomere lengths in longest tertile, those in middle and shortest tertiles showed respective age-adjusted odds ratios
- Strongest associations found for subjects with poorly differentiated carcinomas
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Serum calcium levels are elevated among women with untreated postmenopausal breast cancer
Cancer Causes and Control, 11/03/09
Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents
Annals of Oncology, 11/02/09
Evaluating the combined effect of comorbidity and prostate-specific antigen kinetics on the risk of death in men after prostate-specific antigen recurrence
Journal of Clinical Oncology, 11/02/09
Today in Gynecologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Ovarian cancer screening and early detection
Women's Health, 11/04/09
Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: A phase 3, open-label, randomised controlled trial
The Lancet, 11/23/09
Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia
New England Journal of Medicine, 11/06/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


